150 related articles for article (PubMed ID: 930491)
21. [Characteristics of central neurotransmitter metabolism in hereditary extrapyramidal disorders].
Iwanowa-Smolenskaja JA; Barchatowa WP
Neurol Neurochir Pol; 1981; 15(4):377-80. PubMed ID: 7329505
[TBL] [Abstract][Full Text] [Related]
22. Chronobiology of catecholamine excretion in different age groups.
Lakatua DJ; Nicolau GY; Bogdan C; Plinga L; Jachimowicz A; Sackett-Lundeen L; Petrescu E; Ungureanu E; Haus E
Prog Clin Biol Res; 1987; 227B():31-50. PubMed ID: 3628343
[TBL] [Abstract][Full Text] [Related]
23. [Experience with L-DOPA treatment of children with dystonia musculorum deformans and dystonic hyperkineses in infantile cerebral palsy].
Bondarenko ES; Malyshev IuI
Zh Nevropatol Psikhiatr Im S S Korsakova; 1985; 85(10):1471-5. PubMed ID: 4072505
[TBL] [Abstract][Full Text] [Related]
24. [Catecholamine metabolism in manic-depressive psychosis].
Usherenko LS
Fiziol Zh; 1970; 16(3):393-9. PubMed ID: 5509683
[No Abstract] [Full Text] [Related]
25. [Carbohydrate metabolism disorders in dystonia musculorum deformans (torsion) and its dynamics after stereotaxic surgery].
Voĭtyna SV; Kandel' EI; El'ner AM
Zh Nevropatol Psikhiatr Im S S Korsakova; 1968; 68(2):170-3. PubMed ID: 4871962
[No Abstract] [Full Text] [Related]
26. [Characteristics of the clinical course, pathogenesis and treatment of torsion dystonia in childhood].
Markova ED
Zh Nevropatol Psikhiatr Im S S Korsakova; 1989; 89(8):32-5. PubMed ID: 2588895
[TBL] [Abstract][Full Text] [Related]
27. [Basis, clinical picture and therapy of diseases of the extrapyramidal-motoric system (EPMS)].
Völler GW; Deze J
Z Allgemeinmed; 1975 Mar; 51(8):353-73. PubMed ID: 1094755
[No Abstract] [Full Text] [Related]
28. [Catecholamine metabolism in extrapyramidal disorders in patients with chronic hypertensive encephalopathy].
Barkhatova VP; Lebedeva NV; Dashdorzhiĭn O; Demina EG; Larskiĭ EG
Zh Nevropatol Psikhiatr Im S S Korsakova; 1990; 90(7):32-6. PubMed ID: 2175086
[TBL] [Abstract][Full Text] [Related]
29. [Microelement metabolism in patients with hereditary extrapyramidal diseases].
Borisova TV
Zh Nevropatol Psikhiatr Im S S Korsakova; 1978; 78(2):217-21. PubMed ID: 147595
[TBL] [Abstract][Full Text] [Related]
30. [Catecholamine concentration in the blood and excretion in the urine in different forms of progressive muscular dystrophy].
Badalian LO; Temin PA; Dzhabarov BD; Bespalova VA; Kret LA
Zh Nevropatol Psikhiatr Im S S Korsakova; 1984; 84(3):339-42. PubMed ID: 6426220
[TBL] [Abstract][Full Text] [Related]
31. [Sensitivity and specificity of the determination of urinary catecholamines and their acid metabolites in the diagnosis of neuroblastoma in children].
Horsmans Y; Desager JP; Harvengt C
Bull Cancer; 1990; 77(10):985-9. PubMed ID: 2249018
[TBL] [Abstract][Full Text] [Related]
32. [The pathogenetic significance of metabolic disorders in hereditary extrapyramial diseases].
Tkachev RA; Markova ED; Gotovtseva EV; Bauman LK; Barkhatova VP
Zh Nevropatol Psikhiatr Im S S Korsakova; 1970; 70(4):512-20. PubMed ID: 4250562
[No Abstract] [Full Text] [Related]
33. Study of some biological indices of the state of the sympathoadrenaline system under the effect of polychlorocamphene.
Kuz'minskaya UA; Ivanitskiĭ VA
Environ Health Perspect; 1979 Jun; 30():91-5. PubMed ID: 446464
[TBL] [Abstract][Full Text] [Related]
34. [State of the adrenergic and cholinergic systems of schizophrenic patients during the process of psychopharmacotherapy].
Krupenina LB; Vinogradov MV
Zh Nevropatol Psikhiatr Im S S Korsakova; 1980; 80(5):737-45. PubMed ID: 6106335
[TBL] [Abstract][Full Text] [Related]
35. [Catecholamine metabolism in Huntington's chorea (in patients and their phenotypically healthy relatives)].
Magalov ShI; Dadali EL
Zh Nevropatol Psikhiatr Im S S Korsakova; 1980; 80(8):1158-63. PubMed ID: 6452012
[TBL] [Abstract][Full Text] [Related]
36. [Effect of halothane on catecholamine metabolism in the brain stem of rats].
Schulte J
Arzneimittelforschung; 1976; 26(3):324-7. PubMed ID: 989321
[TBL] [Abstract][Full Text] [Related]
37. The pharmacology of extrapyramidal movement disorders.
Klawans HL
Monogr Neural Sci; 1973; 2():1-136. PubMed ID: 4271860
[No Abstract] [Full Text] [Related]
38. [Catecholamine metabolism in essential tremor].
Barkhatova VP; Ivanova-Smolenskaia IA
Zh Nevropatol Psikhiatr Im S S Korsakova; 1990; 90(3):10-4. PubMed ID: 2163146
[TBL] [Abstract][Full Text] [Related]
39. [Disorders of catecholamine metabolism in infantile autism. Comparative study of 22 autistic children].
Ferrari P; Bursztejn C; Dreux C; Braconnier A; Zarifian E; Lancrenon S; Fermanian J
Encephale; 1989; 15(2):255-62. PubMed ID: 2752959
[TBL] [Abstract][Full Text] [Related]
40. [Modifications of catecholamine metabolism under the effect of a decarboxylase inhibitor associated with L-dopa and desipramine in patients with depressive and parkinsonian syndromes].
Geissbuhler F; Bartholini G; Gaillard JM; Tissot R
Encephale; 1971; 60(3):189-209. PubMed ID: 5119348
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
